Schedule 13G ownership disclosure

MOLECULIN BIOTECH INC

Security class unavailable · CUSIP: 60855D101

Event date: Unavailable

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
591,954
Percent of class
0.9500%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001104659-21-018651
Form type
SC 13G/A
Filer
Moleculin Biotech, Inc.
CIK
CIK 1659617
Filed
Feb 10, 2021
Reporting period
—
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub